The company’s VP Vaccine Sciences, Luc Gagnon, recently presented to the World Vaccine Congress alongside Valentina Bernasconi of CEPI
Nexelis, a provider of assay and biomarker development and laboratory testing services, has won best central/specialty laboratory in Terrapinn’s Vaccine Industry Excellence (ViE) awards on May, 5 2021 at the World Vaccine Congress.
“The World Vaccine Congress and Terrapin contacts hundreds of companies to determine the ViE finalists in each category in order to determine which are most outstanding in supporting vaccine research,” said Nexelis CEO Benoit Bouche. “We were pleased to join our nominated peers, but to win is wonderful regonition of the hard work of the entire Nexelis team and of our customers, who allowed us to partner with them to develop these critical vaccine therapies.”
The company’s VP Vaccine Sciences, Luc Gagnon, recently presented to the World Vaccine Congress alongside Valentina Bernasconi of CEPI. The two companies partnered to support the global response to the COVID-19 pandemic, with Nexelis serving as CEPI’s referral lab for humoral and cellular testing for SARS-CoV-2 and its variants, evaluating vaccines in antivirals in all preclinical and clinical phases.